{"id":"NCT00736840","sponsor":"Meridian Bioscience, Inc.","briefTitle":"BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis","officialTitle":"Pivotal Study to Evaluate the Efficacy and Safety of the BreathID® System for Detection of Cirrhosis Using the ¹³C-methacetin Breath Test(MBT)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-08","primaryCompletion":"2009-09","completion":"2009-09","firstPosted":"2008-08-18","resultsPosted":"2012-03-16","lastUpdate":"2023-01-12"},"enrollment":414,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"SINGLE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Chronic Liver Disease"],"interventions":[{"type":"DEVICE","name":"c13 methacetin solution with breath analyzer","otherNames":[]}],"arms":[{"label":"CLD (chronic liver disease)","type":"OTHER"}],"summary":"This trial is a pivotal trial to validate the use of a 13 C labeled substrate called methacetin and the BreathID automatic breath testing system, for determination of cirrhosis in patients with chronic liver disease.","primaryOutcome":{"measure":"Number of Subjects With Likelihood of Cirrhosis Based on \"Hepatic Impairment Score\" (HIS)","timeFrame":"Study day 1 after a 1 hour test","effectByArm":[{"arm":"CLD (Chronic Liver Disease)","deltaMin":146,"sd":null}],"pValues":[{"comp":"OG000","p":"0.0924"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":15},"locations":{"siteCount":11,"countries":["United States","Israel"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":414},"commonTop":[]}}